Innerwell
Innerwell At-Home Psychedelic Therapy in AZ, CA, CO, CT, DE, FL, GA, ID, IL, IA, KS, KY, MA, MD, ME, MI, MN, MT, NC, NE, NJ, NH, NY, NV, OH, OR, PA, TN, TX, UT, VA, VT, WA, WI and WY
United States · $3.0M raised
- Website
- helloinnerwell.com
- Total Funding
- $3.0M
- Last Round
- $3.0M Pre-SeedMay 2022
- Rounds
- 1
About
At-home psychedelic therapy platform combining licensed therapist guidance with ketamine treatment.
Summary
Innerwell is a Healthcare company based in United States. It has raised $3.0M in total across 1 round, most recently a $3.0M Pre-Seed round in May 2022. Investors include Greycroft, Gershon Capital and GreenPoint Partners.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2022
Investors
Similar Companies
Telehealth platform providing personalized health and wellness treatments for men and women, cove...
COMPASS Pathways is dedicated to accelerating patient access to evidence-based innovation in ment...
Workforce mental health platform that uses AI-powered matching to connect employees with high-qua...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...